Superficial Basal Cell Carcinoma Clinical Trial
Official title:
Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma
The purpose of this study is to determine the safety and tolerability of pharmaceutical compound (API 31510) topical cream topically applied to superficial basal cell carcinomas to obtain preliminary efficacy data for the treatment of superficial basal cell carcinomas by API 31510 topical cream. The study population will include one hundred and sixty (160) otherwise healthy male or female adults with one or more histologically confirmed superficial basal cell carcinoma lesions. One target lesion with an area of less than one inch will be designated for study treatment.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04552990 -
Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma
|
Phase 2 | |
Active, not recruiting |
NCT03573401 -
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
|
Phase 3 | |
Completed |
NCT03012009 -
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02270645 -
Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser
|
N/A | |
Completed |
NCT00469417 -
Metvix PDT Versus Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma
|
Phase 3 | |
Recruiting |
NCT05381597 -
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
|
Phase 2/Phase 3 | |
Terminated |
NCT00994240 -
Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC
|
N/A | |
Completed |
NCT00189306 -
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
|
Phase 3 | |
Recruiting |
NCT05157763 -
A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma
|
Phase 1/Phase 2 | |
Recruiting |
NCT04744935 -
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
|
N/A | |
Completed |
NCT05628714 -
A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma
|
||
Completed |
NCT00432185 -
To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC
|
Phase 2 | |
Recruiting |
NCT01491711 -
Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate
|
Phase 4 | |
Completed |
NCT04470726 -
Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma
|
Phase 1/Phase 2 | |
Completed |
NCT01325688 -
PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities
|
Phase 2 | |
Recruiting |
NCT05713760 -
Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults
|
Phase 2 |